LifeSci Acquisition II Corp. intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities in the healthcare industry. The company was founded in 2019 and is based in New York, New York.
IPO Year: 2020
Exchange: NASDAQ
Website: lifesciacquisition.com/spac-2/
| Date | Price Target | Rating | Analyst |
|---|
8-K - Science 37 Holdings, Inc. (0001819113) (Filer)
8-K - Lifesci Acquisition II Corp. (0001819113) (Filer)
424B3 - Lifesci Acquisition II Corp. (0001819113) (Filer)
EFFECT - Lifesci Acquisition II Corp. (0001819113) (Filer)
S-4/A - Lifesci Acquisition II Corp. (0001819113) (Filer)
S-4/A - Lifesci Acquisition II Corp. (0001819113) (Filer)
10-K - Lifesci Acquisition II Corp. (0001819113) (Filer)
S-4 - Lifesci Acquisition II Corp. (0001819113) (Filer)
425 - Lifesci Acquisition II Corp. (0001819113) (Subject)
SC 13G - Lifesci Acquisition II Corp. (0001819113) (Subject)
Fastest customizable press release news feed in the world
Science 37 to debut on Nasdaq as a publicly traded company under ticker symbol "SNCE"Business combination will provide Science 37 with approximately $235 million in cash proceeds to support continued growthScience 37 to fuel its mission to enable universal access to clinical research which has proven to accelerate patient enrollment, minimize patient burden, and include underserved patient populations Investments targeted to enhance the Science 37 Operating System to decentralize clinical trial execution and enable more agile clinical trials LOS ANGELES and NEW YORK, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Science 37, Inc., the Operating System for today's agile clinical trials, announced today
NEW YORK, June 16, 2021 (GLOBE NEWSWIRE) -- LifeSci Acquisition II Corp. (NASDAQ:LSAQ), a blank check company formed for the purpose of pursuing targets that are focused on healthcare innovation, today announced the confidential submission with the U.S. Securities and Exchange Commission ("SEC") of a draft registration statement on Form S-4 (the "Registration Statement") relating to its previously announced proposed business combination with Science 37, Inc. About LifeSci Acquisition II Corp. LifeSci Acquisition II Corp. (NASDAQ:LSAQ) is a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganizat
Transaction values Science 37 at an enterprise value of approximately $1.05 billion at closing Positions Science 37 with a balance sheet of up to $250 million to fund its decentralized trial technology platform, extend into new adjacencies, and power the next generation in clinical research $80 million via LifeSci Acquisition II Corp., a special purpose acquisition company with no public warrants $200 million via fully committed and upsized PIPE from leading institutional and strategic investors including Redmile Group; funds and accounts managed by BlackRock; Casdin Capital; dRx Capital (Novartis Pharma AG); LifeSci Venture Partners; Lux Capital; Mubadala Capital, the asset manageme
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
3 - Science 37 Holdings, Inc. (0001819113) (Issuer)
3 - Science 37 Holdings, Inc. (0001819113) (Issuer)
3 - Science 37 Holdings, Inc. (0001819113) (Issuer)
4/A - Science 37 Holdings, Inc. (0001819113) (Issuer)
4 - Science 37 Holdings, Inc. (0001819113) (Issuer)
3 - Science 37 Holdings, Inc. (0001819113) (Issuer)
4 - Science 37 Holdings, Inc. (0001819113) (Issuer)
4 - Science 37 Holdings, Inc. (0001819113) (Issuer)
4 - Science 37 Holdings, Inc. (0001819113) (Issuer)
4/A - Science 37 Holdings, Inc. (0001819113) (Issuer)
This live feed shows all institutional transactions in real time.
SC 13D - Science 37 Holdings, Inc. (0001819113) (Subject)
SC 13D - Science 37 Holdings, Inc. (0001819113) (Subject)
SC 13D - Science 37 Holdings, Inc. (0001819113) (Subject)
SC 13G - Science 37 Holdings, Inc. (0001819113) (Subject)
SC 13G/A - Lifesci Acquisition II Corp. (0001819113) (Subject)
SC 13G - Lifesci Acquisition II Corp. (0001819113) (Subject)
SC 13G - Lifesci Acquisition II Corp. (0001819113) (Subject)
SC 13G - Lifesci Acquisition II Corp. (0001819113) (Subject)